2005
DOI: 10.1111/j.1440-0960.2005.00152.x
|View full text |Cite
|
Sign up to set email alerts
|

Sulfasalazine and dermatitis herpetiformis

Abstract: Dermatitis herpetiformis that is unable to be controlled using dapsone and a gluten-free diet presents a therapeutic challenge. Three cases that responded well to sulfasalazine are presented. Two cases, who were unable to tolerate dapsone, had a rapid response to sulfasalazine, without apparent side-effects. The third case with dapsone-responsive blistering dermatoses, presumed to be dermatitis herpetiformis on the basis of serology, showed an excellent clinical response to sulfasalazine, but after 6 weeks of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0
2

Year Published

2009
2009
2024
2024

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(22 citation statements)
references
References 10 publications
0
20
0
2
Order By: Relevance
“…Monitoring for potential side effects is critical given the risk of hemolytic anemia, methemoglobinemia, neuropathy, and hypersensitivity (discussed in more detail previously in the section describing the use of dapsone in the treatment of BP). Sulfasalazine and sulfamethoxypyridazine can be useful in patients who cannot tolerate dapsone or when dapsone is ineffective 98,99 ; however, the mainstay of therapy is initiation of a gluten-free diet, as this reduces the need for medication, resolves underlying enteropathy, and reduces the risk of lymphoma in these patients. 100 Patients should be referred to a dietician for guidance on adhering to a gluten-free diet, as many food ingredients contain gluten.…”
Section: Dermatitis Herpetiformismentioning
confidence: 99%
“…Monitoring for potential side effects is critical given the risk of hemolytic anemia, methemoglobinemia, neuropathy, and hypersensitivity (discussed in more detail previously in the section describing the use of dapsone in the treatment of BP). Sulfasalazine and sulfamethoxypyridazine can be useful in patients who cannot tolerate dapsone or when dapsone is ineffective 98,99 ; however, the mainstay of therapy is initiation of a gluten-free diet, as this reduces the need for medication, resolves underlying enteropathy, and reduces the risk of lymphoma in these patients. 100 Patients should be referred to a dietician for guidance on adhering to a gluten-free diet, as many food ingredients contain gluten.…”
Section: Dermatitis Herpetiformismentioning
confidence: 99%
“…As these mentioned medications also induce adverse effects, controls are necessary monthly or 6 monthly. Enteric-coated forms of the drugs could be prescribed (35) .…”
Section: Sulfasalazine and Sulphamethoxypyridazinementioning
confidence: 99%
“…34,39 While dapsone is the mainstay of pharmacologic therapy for DH, several reports have described successful treatment with sulfasalazine and sulfamethoxypyridazine. 1,[41][42][43] It is likely that these medications are effective because of their metabolism to sulfapyridine, and that the latter is therapeutic via a mechanism similar to that of dapsone. 1,34,41 Because sulfasalazine is variably absorbed, clinical outcome may be less predictable; therefore, it is considered a second-line agent to treat DH.…”
Section: Management Key Pointsmentioning
confidence: 97%